Table 2 Compliance
Opioid (n = xxx) | Placebo (n = xxx) | |
|---|---|---|
GP prescription daily dose of study medication — either opioid or placebo (mg/day) | Mean (95% CI), n | Mean (95% CI), n |
Week 1 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 2 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 3 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 4 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 5 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 6 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Cumulative dose (over entire treatment period) | xxx mgs | xxx mgs |
Self-reported daily dose (mg/day) | Mean (95% CI), n | Mean (95% CI), n |
Week 1 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 2 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 3 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 4 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 5 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Week 6 | xx.x (xx.x to xx.x), n | xx.x (xx.x to xx.x), n |
Cumulative dose | xxx mgs | xxx mgs |
Participants returning study medicines | n/N (%) | n/N (%) |
Participants consuming ≥80% of prescribed dose | ||
Per participant medicine dairy | n/N (%) | n/N (%) |
Per returned medicines | n/N (%) | n/N (%) |
Participants discontinuing study medication | ||
n/N (%) | n/N (%) | |
Reasons for discontinuation | ||
Pain resolved | n/N (%) | n/N (%) |
Felt medicine was ineffective | n/N (%) | n/N (%) |
Others | n/N (%) | n/N (%) |
Assessment of participant blinding (participant estimation) | ||
Opioid | n/N (%) | n/N (%) |
Placebo | n/N (%) | n/N (%) |
Do not know | n/N (%) | n/N (%) |